FGG Human

Fibrinogen Gamma Chain Human Recombinant
Cat. No.
BT8897
Source
Escherichia Coli.
Synonyms
Fibrinogen gamma chain isoform gamma-A, Fibrinogen gamma chain, PRO2061.
Appearance
Sterile Filtered clear solution.
Purity
Greater than 90.0% as determined by SDS-PAGE.
Usage
Prospec's products are furnished for LABORATORY RESEARCH USE ONLY. They may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

FGG Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 434 amino acids (27-437 a.a) and having a molecular mass of 48.9kDa.
FGG is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
Fibrinogen gamma chain isoform gamma-A (FGG) is a crucial component of fibrinogen, a glycoprotein found in blood that plays a vital role in blood clotting. Composed of three pairs of distinct polypeptide chains, FGG works in conjunction with fibrinogen alpha (FGA) and fibrinogen beta (FGB) to form an insoluble fibrin matrix. When a blood vessel is injured, the enzyme thrombin acts upon FGG, converting it into fibrin, the primary protein component of blood clots. This process is essential for hemostasis, preventing excessive bleeding. Beyond its role in clot formation, FGG contributes to the initial stages of wound healing by stabilizing the wound site and guiding cell migration during the re-epithelialization process. Furthermore, various cleavage products generated from fibrinogen and fibrin actively participate in cell adhesion and spreading, exhibit vasoconstrictor and chemotactic properties, and stimulate the growth of several cell types. Maternal fibrinogen is particularly critical for a healthy pregnancy. Genetic mutations affecting the FGG gene can lead to bleeding disorders like dysfibrinogenemia, hypofibrinogenemia, and thrombophilia. Conversely, the accumulation of fibrin is associated with infections, providing protection against hemorrhage induced by interferon gamma (IFN-γ).
Description
Recombinant FGG Human, expressed in E. coli, is a single, non-glycosylated polypeptide chain. It consists of 434 amino acids (specifically, residues 27 to 437) and has a molecular weight of 48.9 kDa. The protein includes a 23-amino acid His-tag fused at its N-terminus. Purification is achieved using proprietary chromatographic techniques.
Physical Appearance
A clear solution that has undergone sterile filtration.
Formulation
The FGG protein solution has a concentration of 0.5 mg/ml and is formulated in a buffer containing phosphate-buffered saline (pH 7.4), 10% glycerol, and 1 mM DTT.
Stability
For short-term storage (up to 2-4 weeks), keep at 4°C. For extended storage, freeze at -20°C. The addition of a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. It's important to avoid repeated freeze-thaw cycles.
Purity
Purity is determined to be greater than 90.0% using SDS-PAGE analysis.
Synonyms
Fibrinogen gamma chain isoform gamma-A, Fibrinogen gamma chain, PRO2061.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSYVATRDN CCILDERFGS YCPTTCGIAD FLSTYQTKVD KDLQSLEDIL HQVENKTSEV KQLIKAIQLT YNPDESSKPN MIDAATLKSR KMLEEIMKYE ASILTHDSSI RYLQEIYNSN NQKIVNLKEK VAQLEAQCQE PCKDTVQIHD ITGKDCQDIA NKGAKQSGLY FIKPLKANQQ FLVYCEIDGS GNGWTVFQKR LDGSVDFKKN WIQYKEGFGH LSPTGTTEFW LGNEKIHLIS TQSAIPYALR VELEDWNGRT STADYAMFKV GPEADKYRLT YAYFAGGDAG DAFDGFDFGD DPSDKFFTSH NGMQFSTWDN DNDKFEGNCA EQDGSGWWMN KCHAGHLNGV YYQGGTYSKA STPNGYDNGI IWATWKTRWY SMKKTTMKII PFNRLTIGEG QQHHLGGAKQ AGDV.

Product Science Overview

Introduction

The Fibrinogen Gamma Chain (FGG) is a crucial component of fibrinogen, a blood-borne glycoprotein involved in blood clotting. Fibrinogen is composed of three pairs of nonidentical polypeptide chains: alpha, beta, and gamma. The gamma chain plays a significant role in the formation of fibrin, the primary protein involved in blood clot formation following vascular injury .

Structure and Function

The gamma chain of fibrinogen is encoded by the FGG gene, located on chromosome 4 in humans . The protein encoded by this gene is essential for the conversion of fibrinogen to fibrin by thrombin, which is a critical step in the blood coagulation process . The gamma chain also has various cleavage products that regulate cell adhesion, spreading, vasoconstriction, chemotactic activities, and act as mitogens for several cell types .

Recombinant Fibrinogen Gamma Chain

Recombinant human fibrinogen gamma chain is produced using DNA sequences encoding the human FGG gene. This recombinant protein is often expressed in yeast and is used in various research and clinical applications . The recombinant protein typically consists of 285 amino acids and has a predicted molecular mass of 32.2 kDa . It is usually lyophilized from sterile PBS and can be stored under sterile conditions at -20°C to -80°C .

Clinical Significance

Mutations in the FGG gene can lead to several disorders, including dysfibrinogenemia, hypofibrinogenemia, and thrombophilia . These conditions affect the blood’s ability to clot properly, leading to either excessive bleeding or clotting. Elevated levels of fibrinogen gamma chain have been associated with various diseases, including coronary artery disease and deep vein thrombosis . Additionally, abnormal expression of FGG mRNA has been observed in hepatocellular carcinoma (HCC) patients, suggesting its potential role as a predictor of clinical progression in these patients .

Applications

Recombinant fibrinogen gamma chain is used in various research applications, including studies on blood coagulation, cell adhesion, and cancer research. Its high purity and stability make it a valuable tool for understanding the molecular mechanisms underlying these processes .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.